Newswires
Submission of Matters to a Vote of Security Holders – Form 8-K
goco-20230523
UNITED STATES
WASHINGTON, DC 20549
GoHealth, Inc.
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 23, 2023
_________________________
(Exact name of registrant as specified in its charter)
_________________________
| 001-39390 | 85-0563805 | |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
| 60654 | |
| (Address of principal executive offices) | ( |
(312) 386-8200
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
_________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425). |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12). |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)). |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)). |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | on which registered |
| Class A Common Stock, |
GOCO | The Nasdaq Global Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
On May 23, 2023 , the Company held its 2023 Annual Meeting of Stockholders (the "Annual Meeting"). A total of 19,307,696 shares of the Company's Preferred Stock and Class A and Class B common stock (collectively, "Stock") were present in person or represented by proxy at the Annual Meeting, representing approximately 74% percent of the Company's outstanding Stock as of the March 28, 2023 record date. The following are the voting results for the proposals considered and voted upon at the Annual Meeting, each of which was described in the Company's Definitive Proxy Statement filed with the Securities and Exchange Commission on April 11, 2023 .
Item 1 - Election of three Class III directors for a term of office expiring on the date of the annual meeting of stockholders to be held in 2026 and until their respective successors have been duly elected and qualified.
| Votes FOR | Votes WITHHELD | Broker Non-Votes | |
| 16,476,370 | 206,338 | 2,624,988 | |
| 16,482,346 | 200,362 | 2,624,988 | |
| 16,668,150 | 14,558 | 2,624,988 |
Item 2 - Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023 .
| Votes FOR | Votes AGAINST | Votes ABSTAINED | Broker Non-Votes |
| 19,286,046 | 12,192 | 9,458 | 0 |
Item 3 - Approval on an advisory basis, the compensation of the Company's named executive officers.
| Votes FOR | Votes AGAINST | Votes ABSTAINED | Broker Non-Votes |
| 16,604,620 | 73,103 | 4,985 | 2,624,988 |
Based on the foregoing voting results, Clinton P. Jones , Jeremy W. Gelber , and Karolina H. Hilu were elected as Class III directors and Items 2 and 3 were approved.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: | By: | /s/ |
|
|
Chief Legal Officer
|
Attachments
Disclaimer
SINGULAR GENOMICS SYSTEMS, INC. FILES (8-K) Disclosing Submission of Matters to a Vote of Security Holders
President Akufo-Addo Urges African Leaders to Support AfCFTA Boldly
Advisor News
- Industry groups applaud House passage of Financial Exploitation Prevention Act
- Younger workers more likely to be eligible for a retirement plan after changing jobs
- Bank of America community event unpacks sales tax hike, small business struggles
- CONGRESSMAN VALADAO DEMANDS ANSWERS FROM CALIFORNIA OVER HEALTHCARE TAX HIKE
- How executive benefits impact an estate plan
More Advisor NewsAnnuity News
- State Farm’s agency overhaul: What distribution can learn
- IRI, ACLI express support for CLEAR Forms Act
- A new era at the Federal Reserve
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Tuesday Session
- Why annuities are gaining traction with younger investors
More Annuity NewsHealth/Employee Benefits News
- Maryland health insurers want to raise premiums an average 13.7% for individual plans in 2027
- Maryland health insurance rates could rise 13.7% in 2027 under proposal
- Millions drop Obamacare health coverage after subsidies expire and costs rise
- Improving how we deliver healthcare in Idaho
- Healthcare system needs a public option
More Health/Employee Benefits NewsLife Insurance News
- AM Best Affirms Credit Ratings of Misr Insurance Company
- State Farm’s agency overhaul: What distribution can learn
- They Allegedly Enrolled People In Life Insurance Without Consent. Then Death Claims Paid Out
- How much do state residents need to retire comfortably?
- How executive benefits impact an estate plan
More Life Insurance News